Cigna Group (CI)
(Real Time Quote from BATS)
$351.78 USD
-3.16 (-0.89%)
Updated Sep 24, 2024 09:54 AM ET
3-Hold of 5 3
A Value C Growth F Momentum B VGM
Price, Consensus and EPS Surprise
CI 351.78 -3.16(-0.89%)
Will CI be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for CI based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for CI
UnitedHealth at 19.09X P/E: Worth the Price or Time to Take Profits?
Cigna's Health Benefits Unit Launches a New E-Treatment Option
CI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
Cigna Stock Gains 26% in a Year: What Lies Ahead for Investors?
Other News for CI
Our Top 10 Dividend Growth Stocks - September 2024
Express Scripts Comments on FTC's Reckless Insulin Action
UnitedHealth, Cigna, CVS PBMs targeted by FTC over inflated insulin prices
What You Missed On Wall Street On Friday
FTC sues CVS, Cigna, UnitedHealth over insulin drug prices